Clinical trials
Recruiting Phase 1 Endometrial Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
54 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 8 |
| 2024 | 12 |
| 2025 | 17 |
| 2026 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 54 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 4 |
| Eli Lilly and Company | 3 |
| Memorial Sloan Kettering Cancer Center | 2 |
| SystImmune Inc. | 2 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| Whitehawk Therapeutics, Inc. | 2 |
| Aaron Wolfson | 1 |
| Abramson Cancer Center at Penn Medicine | 1 |
| ArriVent BioPharma, Inc. | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endometrial Neoplasms | 54 |
| Ovarian Neoplasms | 26 |
| Carcinoma, Non-Small-Cell Lung | 19 |
| Breast Neoplasms | 14 |
| Colorectal Neoplasms | 14 |
| Squamous Cell Carcinoma of Head and Neck | 13 |
| Triple Negative Breast Neoplasms | 13 |
| Uterine Cervical Neoplasms | 12 |
| Neoplasm Metastasis | 10 |
| Stomach Neoplasms | 9 |
Trials
Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.